Liver steatosis assessment: Correlations among pathology, radiology, clinical data and automated image analysis software

Pathology Research and Practice

Volumn 209, Issue 6, 2013, Pages 371-379

  Lee, Michael J ^a   Bagci, Pelin ^a   Kong, Jun ^b   Vos, Miriam B ^a   Sharma, Puneet ^a,c   Kalb, Bobby ^a,c   Saltz, Joel H ^b   Martin, Diego R ^a,c   Adsay, N Volkan ^a   Farris, Alton B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Image analysis; Liver; Magnetic resonance imaging (MRI); Morphometry; Steatosis

Indexed keywords

ALBUMIN;

ADULT; ALGORITHM; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER PROGRAM; FATTY LIVER; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER TRANSPLANTATION; OBSERVER VARIATION; PATHOLOGY; RADIOLOGY;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ALGORITHMS; ASPARTATE AMINOTRANSFERASES; AUTOMATION, LABORATORY; BIOLOGICAL MARKERS; BIOPSY; CHILD; FATTY LIVER; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INTERNATIONAL NORMALIZED RATIO; LINEAR MODELS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; SOFTWARE; YOUNG ADULT;

EID: 84878390629     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.04.001     Document Type: Article

References (45)

1. Aperio | Support 2013, Aperio Technologies, Aperio Technologies Inc., Vista, CA. http://www.aperio.com/support.
2. Image Analysis | Aperio | 2013, Aperio Technologies, Aperio Technologies Inc., Vista, CA. http://www.aperio.com/healthcare/precision/eihc.
3. Arnould L., Cosyn J.P., Rondelez L., Courtoy P. Automated morphometric estimation of liver steatosis. Microsc. Acta Suppl. 1979, 197-203.
4. Bancroft J.D., Spencer L.T. Microtomy: paraffin and frozen. Theory and Practice of Histological Techniques 2008, 93-104. Elsevier, Philadelphia, PA. J.D. Bancroft, M. Gamble (Eds.).
5. Brunt E.M. Pathology of nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 2010, 7:195-203.
6. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999, 94:2467-2474.
7. Brunt E.M., Kleiner D.E., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Torbenson M.S., Yeh M. Misuse of scoring systems. Hepatology 2011, 54:369-370. (author reply 361-370).
8. Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin. Gastroenterol. Hepatol. 2004, 2:1048-1058.
9. Crowley H., Lewis W.D., Gordon F., Jenkins R., Khettry U. Steatosis in donor and transplant liver biopsies. Hum. Pathol. 2000, 31:1209-1213.
10. Donnelly K.L., Smith C.I., Schwarzenberg S.J., Jessurun J., Boldt M.D., Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 2005, 115:1343-1351.
11. Feng S. Steatotic livers for liver transplantation - life-saving but at a cost. Nat. Clin. Pract. Gastroenterol. Hepatol. 2008, 5:360-361.
12. Fiorini R.N., Kirtz J., Periyasamy B., Evans Z., Haines J.K., Cheng G., Polito C., Rodwell D., Shafizadeh S.F., Zhou X., Campbell C., Birsner J., Schmidt M., Lewin D., Chavin K.D. Development of an unbiased method for the estimation of liver steatosis. Clin. Transplant. 2004, 18:700-706.
13. Fischer M.A., Raptis D.A., Montani M., Graf R., Clavien P.A., Nanz D., Alkadhi H., Scheffel H. Liver fat quantification by dual-echo MR imaging outperforms traditional histopathological analysis. Acad. Radiol. 2012, 19:1208-1214.
14. Fishbein T.M., Fiel M.I., Emre S., Cubukcu O., Guy S.R., Schwartz M.E., Miller C.M., Sheiner P.A. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997, 64:248-251.
15. Ford E.S., Giles W.H., Mokdad A.H. Increasing prevalence of the metabolic syndrome among US Adults. Diabetes Care 2004, 27:2444-2449.
16. Francque S.M., Verrijken A., Mertens I., Hubens G., van Marck E., Pelckmans P., Michielsen P., van Gaal L. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. Clin. Gastroenterol. Hepatol. 2012, 10:1162-1168.
17. Franzen L.E., Ekstedt M., Kechagias S., Bodin L. Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting. Mod. Pathol. 2005, 18:912-916.
18. Fromenty B., Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol. Ther. 1995, 67:101-154.
19. Fromenty B., Pessayre D. Impaired mitochondrial function in microvesicular steatosis, effects of drugs, ethanol, hormones and cytokines. J. Hepatol. 1997, 26(Suppl. 2):43-53.
20. Kleiner D.E., Brunt E.M., van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., Sanyal A.J. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
21. Koneru B., Dikdan G. Hepatic steatosis and liver transplantation current clinical and experimental perspectives. Transplantation 2002, 73:325-330.
22. Kong J., Lee M.J., Bagci P., Sharma P., Martin D., Adsay N.V., Saltz J., Farris A.B. Computer-based image analysis of liver steatosis with large-scale microscopy imagery and correlation with magnetic resonance imaging lipid analysis. Proc. IEEE Int. Conf. Bioinform. Biomed. 2011.
23. Li M., Song J., Mirkov S., Xiao S.Y., Hart J., Liu W. Comparing morphometric, biochemical, and visual measurements of macrovesicular steatosis of liver. Hum. Pathol. 2011, 42:356-360.
24. Liquori G.E., Calamita G., Cascella D., Mastrodonato M., Portincasa P., Ferri D. An innovative methodology for the automated morphometric and quantitative estimation of liver steatosis. Histol. Histopathol. 2009, 24:49-60.
25. Markin R.S., Wisecarver J.L., Radio S.J., Stratta R.J., Langnas A.N., Hirst K., Shaw B.W. Frozen section evaluation of donor livers before transplantation. Transplantation 1993, 56:1403-1409.
26. Marsman H., Matsushita T., Dierkhising R., Kremers W., Rosen C., Burgart L., Nyberg S.L. Assessment of donor liver steatosis: pathologist or automated software?. Hum. Pathol. 2004, 35:430-435.
27. Marsman W.A., Wiesner R.H., Rodriguez L., Batts K.P., Porayko M.K., Hay J.E., Gores G.J., Krom R.A. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996, 62:1246-1251.
28. McCormack L., Petrowsky H., Jochum W., Mullhaupt B., Weber M., Clavien P.A. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann. Surg. 2007, 246:940-946. (discussion 946-948).
29. Melin C., Miick R., Young N.A., Ortiz J., Balasubramanian M. Approach to intraoperative consultation for donor liver biopsies. Arch. Pathol. Lab. Med. 2013, 137:270-274.
30. Neuschwander-Tetri B.A., Clark J.M., Bass N.M., van Natta M.L., Unalp-Arida A., Tonascia J., Zein C.O., Brunt E.M., Kleiner D.E., McCullough A.J., Sanyal A.J., Diehl A.M., Lavine J.E., Chalasani N., Kowdley K.V. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 2010, 52:913-924.
31. Nocito A., El-Badry A.M., Clavien P.A. When is steatosis too much for transplantation?. J. Hepatol. 2006, 45:494-499.
32. Permutt Z., Le T.A., Peterson M.R., Seki E., Brenner D.A., Sirlin C., Loomba R. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD. Aliment. Pharmacol. Ther. 2012, 36:22-29.
33. Pineda N., Sharma P., Xu Q., Hu X., Vos M., Martin D.R. Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy - a rapid and accurate technique. Radiology 2009, 252:568-576.
34. Ploeg R.J., D'Alessandro A.M., Knechtle S.J., Stegall M.D., Pirsch J.D., Hoffmann R.M., Sasaki T., Sollinger H.W., Belzer F.O., Kalayoglu M. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993, 55:807-813.
35. Reeder S.B., Cruite I., Hamilton G., Sirlin C.B. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J. Magn. Reson. Imaging 2011, 34. (spcone).
36. Riely C.A. Acute fatty liver of pregnancy. Semin. Liver Dis. 1987, 7:47-54.
37. Roullier V., Cavaro-Menard C., Guillaume C., Aube C. Fuzzy algorithms to extract vacuoles of steatosis on liver histological color images. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007, 5575-5578. 10.1109/IEMBS.2007.4353610.
38. Saadeh S., Younossi Z.M., Remer E.M., Gramlich T., Ong J.P., Hurley M., Mullen K.D., Cooper J.N., Sheridan M.J. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, 123:745-750.
39. Sharma P., Martin D.R., Pineda N., Xu Q., Vos M., Anania F., Hu X. Quantitative analysis of T2-correction in single-voxel magnetic resonance spectroscopy of hepatic lipid fraction. J. Magn. Reson. Imaging 2009, 29:629-635.
40. Taubman B., Hale D.E., Kelley R.I. Familial reye-like syndrome: a presentation of medium-chain acyl-coenzyme A dehydrogenase deficiency. Pediatrics 1987, 79:382-385.
41. Tiniakos D.G., Vos M.B., Brunt E.M. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu. Rev. Pathol. 2010, 5:145-171.
42. Turlin B., Ramm G.A., Purdie D.M., Laine F., Perrin M., Deugnier Y., Macdonald G.A. Assessment of hepatic steatosis: comparison of quantitative and semiquantitative methods in 108 liver biopsies. Liver Int. 2009, 29:530-535.
43. Younossi Z.M., Stepanova M., Rafiq N., Makhlouf H., Younoszai Z., Agrawal R., Goodman Z. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology 2011, 53:1874-1882.
44. Zaitoun A.M., Al Mardini H., Awad S., Ukabam S., Makadisi S., Record C.O. Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C. J. Clin. Pathol. 2001, 54:461-465.
45. Zubair A., Jamal S., Mubarik A. Morphometric analysis of hepatic steatosis in chronic hepatitis C infection. Saudi J. Gastroenterol. 2009, 15:11-14.